Insider: York Charles N II COO and CFO - Day One Biopharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 278,000 | 0 | 278,000 |
| Value | $1,880,975.80 | $0.00 | $1,880,975.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/18/2025 | DDS | 4,106 | Direct | COM | $6.77 | $27,785.71 | 278,000 |
| 05/16/2025 | DDS | 4,282 | Direct | COM | $6.26 | $26,796.33 | 265,231 |
| 02/18/2025 | DDS | 4,370 | Direct | COM | $11.96 | $52,278.31 | 252,638 |
| 11/18/2024 | DDS | 2,602 | Direct | COM | $13.21 | $34,372.94 | 240,133 |
| 08/16/2024 | DDS | 2,633 | Direct | COM | $14.00 | $36,859.63 | 232,485 |
| 05/16/2024 | DDS | 2,675 | Direct | COM | $16.08 | $43,010.52 | 224,868 |
| 05/03/2024 | DDS | 8,078 | Direct | COM | $17.85 | $144,214.11 | 217,293 |
| 05/02/2024 | DDS | 200 | Direct | COM | $17.90 | $3,579.10 | 225,371 |
| 05/01/2024 | DDS | 52,183 | Direct | COM | $17.89 | $933,397.32 | 225,571 |
| 02/16/2024 | DDS | 2,666 | Direct | COM | $15.25 | $40,651.43 | 277,754 |
| 11/16/2023 | DDS | 956 | Direct | COM | $11.69 | $11,175.64 | 270,170 |
| 08/17/2023 | DDS | 922 | Direct | COM | $13.86 | $12,778.92 | 267,501 |
| 05/16/2023 | DDS | 955 | Direct | COM | $13.12 | $12,531.80 | 264,798 |
| 02/17/2023 | DDS | 9,377 | Direct | COM | $20.03 | $187,790.37 | 262,128 |
| 02/16/2023 | DDS | 930 | Direct | COM | $19.57 | $18,202.89 | 271,505 |
| 01/20/2023 | DDS | 10,000 | Direct | COM | $22.75 | $227,523.00 | 268,810 |
| 12/20/2022 | DDS | 10,000 | Direct | COM | $20.07 | $200,650.00 | 276,497 |
| 11/21/2022 | DDS | 9,700 | Direct | COM | $20.74 | $201,152.78 | 286,797 |
| 11/21/2022 | DDS | 300 | Direct | COM | $21.39 | $6,417.00 | 286,497 |
| 11/16/2022 | DDS | 430 | Direct | COM | $21.46 | $9,227.71 | 296,497 |
| 11/01/2022 | DDS | 10,000 | Direct | COM | $20.03 | $200,313.00 | 294,401 |
| 10/03/2022 | DDS | 10,000 | Direct | COM | $20.05 | $200,473.00 | 304,401 |
| 09/01/2022 | DDS | 8,606 | Direct | COM | $23.16 | $199,308.94 | 315,795 |
| 09/01/2022 | DDS | 1,394 | Direct | COM | $23.80 | $33,175.39 | 314,401 |
| 08/16/2022 | DDS | 1,089 | Direct | COM | $24.31 | $26,473.59 | 324,401 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research